Loading...
Adial Pharmaceuticals, Inc.
ADIL•NASDAQ
Healthcare
Biotechnology
$0.33
$0.08(33.94%)
Adial Pharmaceuticals, Inc. (ADIL) Financial Performance & Statements
Review Adial Pharmaceuticals, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
-20.27%
↓ 20.27%
Net Income Growth
-88.48%
↓ 88.48%
Operating Cash Flow Growth
-1.70%
↓ 1.70%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-218.88%
↓ 218.88%
ROIC
-409.41%
↓ 409.41%
Adial Pharmaceuticals, Inc. (ADIL) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Adial Pharmaceuticals, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $141.00 | $141.00 |
| Gross Profit | $0.00 | $0.00 | -$141.00 | -$141.00 |
| Gross Profit Ratio | $0.00 | |||
| R&D Expenses | $730793.00 | $1.03M | $1.01M | $454278.00 |
| SG&A Expenses | $1.21M | $1.18M | $1.27M | $1.39M |
| Operating Expenses | $1.94M | $2.21M | $2.29M | $1.84M |
| Total Costs & Expenses | $1.94M | $2.21M | $2.29M | $1.85M |
| Interest Income | $53758.00 | $50694.00 | $51404.00 | $22801.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $141.00 | $142.00 | $141.00 | $141.00 |
| EBITDA | -$1.94M | -$2.21M | -$2.29M | -$1.84M |
| EBITDA Ratio | ||||
| Operating Income | -$1.94M | -$2.21M | -$2.29M | -$1.85M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$130059.00 | $19671.00 | -$171068.00 | -$4.63M |
| Income Before Tax | -$2.07M | -$2.19M | -$2.46M | -$6.48M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.07M | -$2.19M | -$2.46M | -$6.48M |
| Net Income Ratio | ||||
| EPS | -$0.11 | -$0.38 | -$0.59 | -$2.19 |
| Diluted EPS | -$0.11 | -$0.38 | -$0.59 | -$2.19 |
| Weighted Avg Shares Outstanding | $18.59M | $5.84M | $4.18M | $2.95M |
| Weighted Avg Shares Outstanding (Diluted) | $18.59M | $5.84M | $4.18M | $2.95M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan